{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T12:46:52Z","timestamp":1770986812248,"version":"3.50.1"},"reference-count":26,"publisher":"The Endocrine Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Gene therapy may be an effective approach to thyroid carcinoma refractory to conventional treatment. A transcriptionally targeted retroviral vector for gene therapy of thyroid carcinomas was generated replacing the viral enhancer with the enhancer sequence of the human thyroglobulin (TG) gene, yielding a chimeric long-terminal repeat. The TG enhancer was used to drive the expression of either a reporter gene (\u03b2-galactosidase) or two therapeutic genes, i.e. the prodrug-activating enzyme thymidine kinase of herpes simplex virus (HSV-TK) and human IL-2, separated by an internal ribosome entry site. The corresponding vector having an unmodified long-terminal repeat was used as control. The targeted vector allowed selective transgene expression and cell killing in differentiated thyroid tumor cells but not in anaplastic thyroid carcinoma cells and nonthyroid cells, as demonstrated by quantitative RT-PCR and cytotoxicity assays. Nude mice injected with tumor cells underwent near complete or complete regression of tumors transduced with the control vector after ganciclovir treatment. On the other hand, infection with the thyroid-specific vector led to regression only of TG-expressing tumors. In addition, tumors expressing human IL-2 showed significant growth retardation, compared with nontransduced tumors while exhibiting signs of necrosis and presence of an inflammatory infiltrate. However, HSV-TK\/IL-2 plus ganciclovir was significantly more efficient than HSV-TK\/IL-2 alone in eradicating tumor masses. Our results indicate that replacement of viral enhancer with TG enhancer confers selectivity of transgene expression in thyroid cells. Thus, the combined thyroid-specific expression of two therapeutic genes (cytokine and suicide genes), although a safe tumor-targeted treatment, would allow an increased anticancer effect.<\/jats:p>","DOI":"10.1210\/jc.2002-020975","type":"journal-article","created":{"date-parts":[[2002,11,2]],"date-time":"2002-11-02T03:22:01Z","timestamp":1036207321000},"page":"5304-5311","source":"Crossref","is-referenced-by-count":24,"title":["Transcriptionally Targeted Retroviral Vector for Combined Suicide and Immunomodulating Gene Therapy of Thyroid Cancer"],"prefix":"10.1210","volume":"87","author":[{"given":"Luisa","family":"Barzon","sequence":"first","affiliation":[{"name":"Department of Histology, Microbiology, and Medical Biotechnologies (L.B., R.B., I.C., E.G., C.P., G.P.), University of Padova, I-35121 Padova;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Bonaguro","sequence":"additional","affiliation":[{"name":"Department of Histology, Microbiology, and Medical Biotechnologies (L.B., R.B., I.C., E.G., C.P., G.P.), University of Padova, I-35121 Padova;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignazio","family":"Castagliuolo","sequence":"additional","affiliation":[{"name":"Department of Histology, Microbiology, and Medical Biotechnologies (L.B., R.B., I.C., E.G., C.P., G.P.), University of Padova, I-35121 Padova;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Chilosi","sequence":"additional","affiliation":[{"name":"Department of Pathology (M.C.), University of Verona, I-37134 Verona;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Gnatta","sequence":"additional","affiliation":[{"name":"Department of Histology, Microbiology, and Medical Biotechnologies (L.B., R.B., I.C., E.G., C.P., G.P.), University of Padova, I-35121 Padova;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Parolin","sequence":"additional","affiliation":[{"name":"Department of Histology, Microbiology, and Medical Biotechnologies (L.B., R.B., I.C., E.G., C.P., G.P.), University of Padova, I-35121 Padova;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Boscaro","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine (M.B.), University of Ancona, I-60100 Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Palu\u0300","sequence":"additional","affiliation":[{"name":"Department of Histology, Microbiology, and Medical Biotechnologies (L.B., R.B., I.C., E.G., C.P., G.P.), University of Padova, I-35121 Padova;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2020071616065737700_R1","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1530\/eje.0.1430447","article-title":"New perspectives for gene therapy in endocrinology.","volume":"143","author":"Barzon","year":"2000","journal-title":"Eur J Endocrinol"},{"key":"2020071616065737700_R2","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1210\/jcem.86.7.7653","article-title":"Gene therapy for thyroid cancer: where do we stand?","volume":"86","author":"Zhang","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616065737700_R3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1006\/viro.1995.9923","article-title":"Tissue-specific gene expression from Mo-MLV retroviral vector with hybrid LTRs containing the murine tyrosinase enhancer\/promoter","volume":"214","author":"Vile","year":"1995","journal-title":"Virology"},{"key":"2020071616065737700_R4","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1128\/JVI.72.1.789-795.1998","article-title":"Exchange of viral promoter\/enhancer elements with heterologous regulatory sequences generates targeted hybrid long terminal repeat vectors for gene therapy of melanoma.","volume":"72","author":"Diaz","year":"1998","journal-title":"J Virol"},{"key":"2020071616065737700_R5","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/sj.gt.3300670","article-title":"Production and characterization of a bicistronic Moloney-based vector expressing human interleukin-2 and herpes simplex virus thymidine kinase for gene therapy of cancer.","volume":"5","author":"Pizzato","year":"1998","journal-title":"Gene Ther"},{"key":"2020071616065737700_R6","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/sj.gt.3300805","article-title":"Gene therapy of glioblastoma multiforme via combined expression of suicide and cytochine genes: a pilot study in humans.","volume":"6","author":"Palu\u0300","year":"1999","journal-title":"Gene Ther"},{"key":"2020071616065737700_R7","doi-asserted-by":"crossref","first-page":"6460","DOI":"10.1073\/pnas.85.17.6460","article-title":"Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges.","volume":"85","author":"Danos","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071616065737700_R8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0167-4781(96)00044-9","article-title":"Identification of a thyroid-specific and cAMP-responsive enhancer in the upstream sequences of the human thyroglobulin promoter.","volume":"1307","author":"Berg","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"2020071616065737700_R9","first-page":"980","article-title":"Improved retroviral vectors for gene transfer and expression.","volume":"7","author":"Miller","year":"1989","journal-title":"Biotechniques"},{"key":"2020071616065737700_R10","first-page":"505","article-title":"Gene therapy of glioblastoma multiforme with bibistronic retroviral vector expressing human IL-2 and HSV-TK","author":"Palu\u0300","year":"2000","journal-title":"In: Walther W, Stein U, eds. Methods in molecular medicine, vol 35: Gene therapy\u2014methods and protocols. Totowa, NJ: Humana Press, Inc.;"},{"key":"2020071616065737700_R11","doi-asserted-by":"crossref","first-page":"7430","DOI":"10.1128\/JVI.69.12.7430-7436.1995","article-title":"High-titre packaging cells producing recombinant retrovirus resistant to human serum.","volume":"69","author":"Cosset","year":"1995","journal-title":"J Virol"},{"key":"2020071616065737700_R12","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1530\/eje.0.1420340","article-title":"Semi-quantitative comparison of the differentiation markers and sodium iodide symporter messenger ribonucleic acids in papillary thyroid carcinomas using RT-PCR.","volume":"142","author":"Tanaka","year":"2000","journal-title":"Eur J Endocrinol"},{"key":"2020071616065737700_R13","first-page":"2889","article-title":"All-trans-retinoic acid modulates expression levels of thyroglobulin and cytokines in a new human poorly differentiated papillary thyroid carcinoma cell line, KTC-1.","volume":"85","author":"Kurebayashi","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616065737700_R14","first-page":"4037","article-title":"Quantitative reverse transcription-polymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma.","volume":"84","author":"Ringel","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616065737700_R15","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1210\/endo.139.9.6286","article-title":"Retrovirus-mediated suicide gene\/prodrug therapy targeting thyroid carcinoma using a thyroid-specific promoter.","volume":"130","author":"Braiden","year":"1998","journal-title":"Endocrinology"},{"key":"2020071616065737700_R16","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1089\/105072501300042749","article-title":"An adenoviral vector transducing tissue specific expression of thymidine kinase under the control of thyroglobulin promoter has high specificity and low toxicity in gene therapy.","volume":"11","author":"Zhang","year":"2001","journal-title":"Thyroid"},{"key":"2020071616065737700_R17","first-page":"834","article-title":"Construction of gene therapy vectors targeting thyroid cells: enhancement of activity and specificity with histone deacetylase inhibitors and agents modulating the cyclic adenosine 3\u2032, 5\u2032-monophosphate pathway and demonstration of activity in follicular and anaplastic thyroid cells.","volume":"86","author":"Kitazono","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616065737700_R18","first-page":"3049","article-title":"Enhanced efficacy of transcriptionally targeted suicide gene\/prodrug therapy for thyroid carcinoma with the Cre-loxP system.","volume":"59","author":"Nagayama","year":"1999","journal-title":"Cancer Res"},{"key":"2020071616065737700_R19","first-page":"3640","article-title":"Transcriptional activation of the thyroglobulin promoter directing suicide gene expression by thyroid transcription factor-1 in thyroid cancer cells.","volume":"61","author":"Shimura","year":"2001","journal-title":"Cancer Res"},{"key":"2020071616065737700_R20","first-page":"202","article-title":"Molecular basis of thyroid cancer.","volume":"15","author":"Farid","year":"1994","journal-title":"Endocr Rev"},{"key":"2020071616065737700_R21","first-page":"3758","article-title":"Combination suicide and cytokine gene therapy for hepatic metastases of colon carcinoma: sustained antitumor immunity prolongs animal survival.","volume":"56","author":"Chen","year":"1996","journal-title":"Cancer Res"},{"key":"2020071616065737700_R22","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1042\/bst0250717","article-title":"Targeted gene therapy for cancer: herpes simplex virus thymidine kinase gene-mediated cell killing leads to anti-tumor immunity that can be augmented by co-expression of cytokines in the tumor cells.","volume":"25","author":"Vile","year":"1997","journal-title":"Biochem Soc Trans"},{"key":"2020071616065737700_R23","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/sj.cgt.7700215","article-title":"Efficacy of herpes simplex virus thymidine kinase in combination with cytokine gene therapy in an experimental metastatic breast model.","volume":"7","author":"Majumdar","year":"2000","journal-title":"Cancer Gene Ther"},{"key":"2020071616065737700_R24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s002620050552","article-title":"Treatment of medullary thyroid carcinoma by combined expression of suicide and interleukin-2 genes.","volume":"48","author":"Soler","year":"1999","journal-title":"Cancer Immunol Immunother"},{"key":"2020071616065737700_R25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1677\/erc.0.0080315","article-title":"An adenoviral vector expression functional heterogenous proteins herpes simplex viral thymidine kinase and human interleukin-2 has enhanced in vivo antitumor activity against medullary thyroid carcinoma.","volume":"8","author":"Zhang","year":"2001","journal-title":"Endocr Relat Cancer"},{"key":"2020071616065737700_R26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/(SICI)1099-1654(200005\/06)10:3<185::AID-RMV285>3.0.CO;2-8","article-title":"Progress with retroviral gene vectors.","volume":"10","author":"Palu","year":"2000","journal-title":"Rev Med Virol"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/87\/11\/5304\/9042673\/jcem5304.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/87\/11\/5304\/9042673\/jcem5304.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T03:07:37Z","timestamp":1594955257000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/87\/11\/5304\/2823519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11,1]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2002,11,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2002-020975","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,11,1]]}}}